OQROSign up free
Insider trade

60 Degrees Pharmaceuticals (SXTP): CEO bought ~$10K

Geoffrey S Dow, CEO at 60 Degrees Pharmaceuticals, bought ~$10K of 60 Degrees Pharmaceuticals shares.

~$10K
Approx. value · 7,350 sh @ $1.38
24K
Holds after · shares reported
Traded
Jun 12, 2026
Filed
Jun 16, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 13, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On May 13, 2026, the Board of Directors (the “Board”) of 60 Degrees Pharmaceuticals, Inc. (the “Company”) appointed Eric Francois to serve as a member of the Board, effective immediately.”
  2. Jun 12, 2026 · this disclosureInsiderCEO purchased ~$10K of SXTP shares in the open market

What came next

  1. Jul 30, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 1 more item)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for 60 Degrees Pharmaceuticals

OQRO holds no insider, Congress, fund or contract record for 60 Degrees Pharmaceuticals dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its SXTP page.

Other recent filings by Geoffrey S Dow, President and CEO

The full history of Geoffrey S Dow, President and CEO is on the profile page.

How this filing works

Explore the data

Common questions

Which 60 Degrees Pharmaceuticals (SXTP) insider traded, and how much?

Geoffrey S Dow, CEO at 60 Degrees Pharmaceuticals, bought ~$10K of 60 Degrees Pharmaceuticals shares. 7,350 shares at $1.38, open market.

When did it happen, and when was it made public?

Traded: Jun 12, 2026. Filed: Jun 16, 2026. That is 4 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

Does this mean SXTP stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at 60 Degrees Pharmaceuticals

Everything OQRO holds on this company is on its SXTP page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Sign up freeAlready have an account? Log in

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data